Doxorubicin conjugates: a practical approach for its cardiotoxicity alleviation-Reference-Cited by-同舟云学术

Doxorubicin conjugates: a practical approach for its cardiotoxicity alleviation

Published:2024-03-03 Issue:3 Volume:21 Page:399-422
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Ibrahim Abed Alqader¹,Nsairat Hamdi²,Al-Sulaibi Mazen²,El-Tanani Mohamed²³,Jaber Areej M.²,Lafi Zainab²,Barakat Rahmeh²,Abuarqoub Duaa Azmi⁴⁵,Mahmoud Ismail Sami⁶,Obare Sherine O¹⁷,Aljabali Alaa A. A.⁸,Alkilany Alaaldin M.⁹,Alshaer Walhan⁵

Affiliation:

1. Department of Nanoscience, Joint School of Nanoscience and Nanoengineering, University of North Carolina at Greensboro, Greensboro, NC, USA

2. Pharmacological and Diagnostic Research Center, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan

3. College of Pharmacy, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates

4. Department of Pharmacology and Biomedical Sciences, Faculty of Pharmacy and Medical Sciences, University of Petra, Amman, Jordan

5. Cell Therapy Center, The University of Jordan, Amman, Jordan

6. Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, The Hashemite University, Zarqa, Jordan

7. Department of Nanoengineering, Joint School of Nanoscience and Nanoengineering, North Carolina Agricultural and Technical State University, Greensboro, NC, USA

8. Faculty of Pharmacy, Department of Pharmaceutical Sciences, Yarmouk University, Irbid, Jordan

9. College of Pharmacy, QU Health, Qatar University, Doha, Qatar

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2024.2343882

Reference219 articles.

1. Doxorubicin: The Good, the Bad and the Ugly Effect

2. Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity

3. Vigevani A, Williamson MJ. Doxorubicin. In: Florey K, editor. Analytical profiles of drug substances. Vol. 9. New York: Academic Press; 1981. p. 245–274.

4. The anthracyclines: will we ever find a better doxorubicin?;Weiss RB;Semin Oncol,1992

5. Toxicity of Doxorubicin (Dox) to different experimental organ systems